# A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

> **NCT01492647** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 18 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** JNJ 10229570-AAA 1.2%
- **DRUG:** JNJ 10229570-AAA 3.6%
- **DRUG:** Color-matched vehicle containing 0 mg of JNJ 10229570-AAA

## Key facts

- **NCT ID:** NCT01492647
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492647, "A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01492647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*